Literature DB >> 22436323

Ketamine for chronic noncancer pain: concerns regarding toxicity.

Rae F Bell1.   

Abstract

PURPOSE OF REVIEW: Ketamine misuse and abuse is on the increase. This review focuses on recent studies on ketamine toxicity in recreational users and possible implications for the use of ketamine in chronic pain therapy. RECENT
FINDINGS: Urological toxicity, hepatotoxicity and cognitive deficits are all reported as adverse effects of the recreational use of ketamine. Urological toxicity and hepatotoxicity have been reported as adverse effects of ketamine in pain therapy.
SUMMARY: These findings may have implications for the clinical use of ketamine in chronic noncancer pain conditions. Until safety issues are resolved, it is suggested that chronic pain treatment involving higher doses and repeated exposure to ketamine be restricted to the context of randomized, controlled trials or clinical audits.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22436323     DOI: 10.1097/SPC.0b013e328352812c

Source DB:  PubMed          Journal:  Curr Opin Support Palliat Care        ISSN: 1751-4258            Impact factor:   2.302


  11 in total

Review 1.  Ketamine as an adjuvant to opioids for cancer pain.

Authors:  Rae F Bell; Christopher Eccleston; Eija A Kalso
Journal:  Cochrane Database Syst Rev       Date:  2017-06-28

2.  Oral ketamine analgesia in chronic pain and problematic rise in blood pressure.

Authors:  Oliver van Hecke; Bruce Guthrie
Journal:  BMJ Case Rep       Date:  2014-11-25

Review 3.  Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy.

Authors:  Marko A Peltoniemi; Nora M Hagelberg; Klaus T Olkkola; Teijo I Saari
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

4.  Optimizing Perioperative Use of Opioids: A Multimodal Approach.

Authors:  Maria F Ramirez; Brinda B Kamdar; Juan P Cata
Journal:  Curr Anesthesiol Rep       Date:  2020-09-07

5.  Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat.

Authors:  T O Lilius; V Jokinen; M S Neuvonen; M Niemi; E A Kalso; P V Rauhala
Journal:  Br J Pharmacol       Date:  2015-06       Impact factor: 8.739

Review 6.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Steven P Cohen; Anuj Bhatia; Asokumar Buvanendran; Eric S Schwenk; Ajay D Wasan; Robert W Hurley; Eugene R Viscusi; Samer Narouze; Fred N Davis; Elspeth C Ritchie; Timothy R Lubenow; William M Hooten
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288

7.  Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Acute Pain Management From the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists.

Authors:  Eric S Schwenk; Eugene R Viscusi; Asokumar Buvanendran; Robert W Hurley; Ajay D Wasan; Samer Narouze; Anuj Bhatia; Fred N Davis; William M Hooten; Steven P Cohen
Journal:  Reg Anesth Pain Med       Date:  2018-07       Impact factor: 6.288

8.  Comeback of ketamine: resurfacing facts and dispelling myths.

Authors:  Abhijit Kumar; Amit Kohli
Journal:  Korean J Anesthesiol       Date:  2021-01-11

9.  Preemptive perineural bupivacaine attenuates the maintenance of mechanical and cold allodynia in a rat spinal nerve ligation model.

Authors:  John L Clifford; Alberto Mares; Jacob Hansen; Dayna L Averitt
Journal:  BMC Anesthesiol       Date:  2015-10-06       Impact factor: 2.217

10.  Prolonged ketamine infusion as a therapy for complex regional pain syndrome: synergism with antagonism?

Authors:  Anthony E Pickering; Candida S McCabe
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.